Necrotizing Ulcerative Gingivitis Treatment Market Share

  • Report ID: 3596
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Necrotizing Ulcerative Gingivitis Treatment Market Share

North American Market Forecast

The market share of necrotizing ulcerative gingivitis (NUG) treatment in North America, amongst the market in all the other regions, is projected to be the largest with a share of about 32% by the end of 2036. The growth of the market can be attributed majorly to the increasing prevalence of oral diseases in developed countries, including the US, backed by poor diet, and high cases of diabetes amongst the people. According to the data from the Centers for Disease Control and Prevention (CDC), more than 1 in every 4 adults, i.e., around 26% of the American population suffers from untreated tooth decay. Moreover, growing health awareness amongst the people and government initiatives to ensure efficient healthcare facilities, are estimated to boost the market growth. Besides this, the rising focus on the advancements in the diagnosis and treatment of different necrotizing gingivostomatitis diseases is also expected to drive market growth. The lack of pure drinking water which contains fluoride or other chemicals leads to teeth disorders and gum diseases thereby rises the chances of necrotizing ulcerative gingivitis and the growth of the market.

APAC Market Statistics

The Asia Pacific necrotizing ulcerative gingivitis (NUG) treatment market is estimated to be the second largest, registering a share of about 28% by the end of 2036. The growth of the market can be attributed to improving the public healthcare system, and growing awareness among people regarding oral hygiene. The increasing population across the region with stress, anxiety, and sleep disorders is estimated to drive market growth across the world. Education about healthy eating habits and mouth rising regularly twice a day or after each meal if required is estimated to reduce the occurrence of necrotizing ulcerative gingivitis disease. The increasing disposable income of people and living standards are changing the eating and drinking habits of people across the region which cause oral issues. Binge drinking of alcohol and regular consumption of tobacco is one of the major reasons for oral issues. The escalating use of antibiotics, ointments, topical pain relief, and solutions for oral health is estimated to drive market growth.

Europe Market Forecast

Further, the market in Europe, amongst the market in all the other regions, is projected to hold a share of 22% by the end of 2036. The growth of the market can be attributed majorly to the increasing preference for oral health across the region. The growing number of hospitals and rising education programs to prevent the drinking of fluoride water are estimated to boost market growth. The increasing number of people suffering from insomnia owing to work and family stress is rising the risk of gingivitis disease. The poor availability of nutritional diets and lack of proper food supply in underdeveloped countries of the region are also anticipated to drive market growth in the coming years. The negligence among people regarding oral health and ignoring issues such as tooth damage, loose teeth, tooth decay, and formation of plaque is expected to propel the growth of the market in this region.

Research Nester
Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3596
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of necrotizing ulcerative gingivitis treatment is evaluated at USD 1.12 Billion.

The necrotizing ulcerative gingivitis treatment market size was valued at USD 1.01 Billion in 2023 and is expected to exceed USD 4.42 Billion by the end of 2036, expanding at over 12.1% CAGR during the forecast period i.e., between 2024-2036. Growing incidences of oral diseases, and poor diet and dental hygiene are the major factors driving the market growth.

North America is likely to be the largest with a share of about 32% by 2036, attributed to increasing prevalence of oral diseases in developed countries, including the US, driven by poor diet, and high cases of diabetes amongst the people.

Novartis International AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Abbott Laboratories, Eli Lilly and Company, Hindustan Antibiotics Limited
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying